Lenalidomide-induced cytokine release syndrome in a patient with multiple myeloma

Leuk Lymphoma. 2014 Jul;55(7):1691-3. doi: 10.3109/10428194.2013.853300. Epub 2014 Jan 28.

Authors

Nobuhiko Nakamura¹, Nobuhiro Kanemura, Yuhei Shibata, Takuro Matsumoto, Ryoko Mabuchi, Hiroshi Nakamura, Junichi Kitagawa, Naoe Goto, Takeshi Hara, Hisashi Tsurumi, Hisataka Moriwaki

Affiliation

¹ First Department of Internal Medicine, Gifu University Graduate School of Medicine , Gifu , Japan.

PMID: 24138307
DOI: 10.3109/10428194.2013.853300

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents / adverse effects*
Antineoplastic Agents / therapeutic use
Cytokines / blood*
Humans
Immunologic Factors / adverse effects*
Immunologic Factors / therapeutic use
Lenalidomide
Male
Multiple Myeloma / blood*
Multiple Myeloma / complications*
Multiple Myeloma / diagnosis
Multiple Myeloma / drug therapy
Thalidomide / adverse effects
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use

Substances

Antineoplastic Agents
Cytokines
Immunologic Factors
Thalidomide
Lenalidomide